A recent study led by ERS/EU RESPIRE2 Marie Curie fellowship recipient Dr Timothy Kidd, and published in EMBO Molecular Medicine, focused on Klebsiella pneumoniae as an important cause of multidrug‐resistant infections. In particular, the study highlights that inactivation of mgrB is shown to confer colistin resistance and to enhance virulence – which may have important implications for the management of patients.
Dr Kidd who received the RESPIRE2 fellowship during the period 2014-2015 carried out research at Queen’s University Belfast (QUB), under the supervision of Prof. José Bengoechea. Following the fellowship, he was able to secure long-term funding to continue his research.
The RESPIRE fellowship enabled Dr Kidd to foster international collaborations in respiratory science, notably exchanges between Europe and his home country of Australia, where he has since returned and is now undertaking research at the University of Queensland in Brisbane.
Speaking of the relationship between his RESPIRE fellowship opportunity and subsequent research success, Dr Kidd highlighted: “I was fortunate to be working with a well-connected and world-class research group, thus extending my research experiences, international profile and collaborations. In particular, during the RESPIRE2 fellowship, I have been able to enhance my capacity to undertake complex and technically demanding research tasks on an independent basis”.
- Read the full publication in the EMBO Molecular Medicine
- Find further information on the ERS/EU RESPIRE2 Marie Curie Fellowship programme
- Learn more about the opportunities offered through new ERS/EU RESPIRE3 Marie Curie Fellowship programme
- Access the ERS Fellowships web page for information on the full range of Fellowship opportunities